Profile picture

Professor Rainer Duesing

Hypertoniezentrum Bonn, Bonn (Germany)
Follow
Logo ESC

Contributor content

Incidence rates of oedema with triple therapy amlodipine/valsartan/HCTZ as compared to valsartan/amlodipine and valsartan/HCTZ dual combination therapy
Presentation
Incidence rates of oedema with triple therapy amlodipine/valsartan/HCTZ as compared to valsartan/amlodipine and valsartan/HCTZ dual combination therapy
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources